Persistent idiopathic facial pain

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:398147G50.1
Who is this for?
Show terms as
2Active trials6Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Persistent idiopathic facial pain (PIFP), formerly known as atypical facial pain, is a chronic pain condition that affects the face. The word 'idiopathic' means the exact cause is unknown. People with this condition experience ongoing facial pain that does not follow the typical pattern of known nerve disorders like trigeminal neuralgia. The pain is usually felt in one area of the face, often described as a deep, aching, burning, or throbbing sensation. It can last for hours or be constant throughout the day, and it may persist for months or even years. The pain typically does not match the area served by any single nerve, which makes it different from other facial pain conditions. It can affect the cheek, jaw, nose, forehead, or around the eyes. The pain may spread over time. There is usually no visible cause found on physical examination, imaging, or lab tests, which can be frustrating for patients. Treatment focuses on managing pain and improving quality of life. Medications commonly used include low-dose tricyclic antidepressants (such as amitriptyline), anticonvulsants (such as gabapentin or pregabalin), and sometimes serotonin-norepinephrine reuptake inhibitors (SNRIs like duloxetine). Cognitive behavioral therapy and other psychological approaches can also help patients cope with chronic pain. Some patients benefit from multidisciplinary pain management programs. While there is no cure, many people find meaningful relief with the right combination of treatments.

Also known as:

Key symptoms:

Constant or near-constant facial painDeep aching or burning sensation in the facePain that does not follow a specific nerve pathwayPain usually on one side of the faceThrobbing or dull facial discomfortPain in the cheek, jaw, or around the eyePain that may spread to other areas of the face over timeNo numbness or loss of sensation in the painful areaPain that is not triggered by touch or chewing (unlike trigeminal neuralgia)Difficulty sleeping due to painAnxiety or depression related to chronic painFatigue from dealing with ongoing pain

Clinical phenotype terms (11)— hover any for plain English
Chronic painHP:0012532DullHP:0025282Acute episodes of neuropathic symptomsHP:0003489Burning mouthHP:0032143Abnormal nervous system morphologyHP:0012639
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

9 events
Jan 2026Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Siriraj Hospital — NA

TrialNOT YET RECRUITING
Nov 2025Treatment of Atypical Resistant Facial Pain

Alenka Spindler-Vesel

TrialENROLLING BY INVITATION
Sep 2025Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)

Hebei Medical University Fourth Hospital — PHASE2

TrialRECRUITING
Sep 2025An Innovative Cognitive-Behavioral Treatment For Chronic Orofacial Pain

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta — NA

TrialRECRUITING
Aug 2025Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis

ImCare Biotech

TrialNOT YET RECRUITING
Jul 2024A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

BeOne Medicines — PHASE1

TrialRECRUITING
Apr 2023Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma

Seoul National University Hospital

TrialACTIVE NOT RECRUITING
Oct 2021Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

Mercator MedSystems, Inc. — PHASE2

TrialRECRUITING
May 2019Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

Glycotest, Inc.

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Persistent idiopathic facial pain.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
N/A1 trial
An Innovative Cognitive-Behavioral Treatment For Chronic Orofacial Pain
N/A
Actively Recruiting
PI: Licia Grazzi, MD (Fondazione IRCCS Istituto Neurologico Carlo Besta) · Sites: Milan · Age: 1870 yrs
Other1 trial
Treatment of Atypical Resistant Facial Pain
Enrolling by Invitation
· Sites: Ljubljana · Age: 1875 yrs

Specialists

6 foundView all specialists →
LM
Licia Grazzi, MD
Specialist
PI on 1 active trial1 Persistent idiopathic facial pain publication
ÖM
Ömer Taylan Akkaya, MD
Specialist
PI on 2 active trials
EM
Ezgi Can, MD
Specialist
PI on 1 active trial
JP
Jorunn L Helbostad, PhD prof
Specialist
PI on 1 active trial
AN
Antoun Nader
CHICAGO, IL
Specialist
PI on 1 active trial
JZ
Jingdong Zhang
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Persistent idiopathic facial pain.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Persistent idiopathic facial painForum →

No community posts yet. Be the first to share your experience with Persistent idiopathic facial pain.

Start the conversation →

Latest news about Persistent idiopathic facial pain

Disease timeline:

New recruiting trial: Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: National Liver Cancer Screening Trial

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: The Application of Serum DNA Methylation for Patients With HCC

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

New recruiting trial: An Innovative Cognitive-Behavioral Treatment For Chronic Orofacial Pain

A new clinical trial is recruiting patients for Persistent idiopathic facial pain

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What tests do I need to rule out other causes of my facial pain?,Which medication would you recommend starting with, and what side effects should I watch for?,Would cognitive behavioral therapy or other psychological approaches help me?,Should I see a pain management specialist or a multidisciplinary pain team?,Are there any procedures or nerve blocks that might help my pain?,How long should I try a medication before we decide if it is working?,What can I do at home to help manage my pain on a daily basis?

Common questions about Persistent idiopathic facial pain

What is Persistent idiopathic facial pain?

Persistent idiopathic facial pain (PIFP), formerly known as atypical facial pain, is a chronic pain condition that affects the face. The word 'idiopathic' means the exact cause is unknown. People with this condition experience ongoing facial pain that does not follow the typical pattern of known nerve disorders like trigeminal neuralgia. The pain is usually felt in one area of the face, often described as a deep, aching, burning, or throbbing sensation. It can last for hours or be constant throughout the day, and it may persist for months or even years. The pain typically does not match the a

How is Persistent idiopathic facial pain inherited?

Persistent idiopathic facial pain follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Persistent idiopathic facial pain typically begin?

Typical onset of Persistent idiopathic facial pain is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Persistent idiopathic facial pain?

Yes — 2 recruiting clinical trials are currently listed for Persistent idiopathic facial pain on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Persistent idiopathic facial pain?

6 specialists and care centers treating Persistent idiopathic facial pain are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.